Witnessing the stock’s movement on the chart, on Wednesday, Soleno Therapeutics Inc (NASDAQ: SLNO) had a quiet start as it plunged -26.59% to $46.87, before settling in for the price of $63.85 at the close. Taking a more long-term approach, SLNO posted a 52-week range of $41.50-$90.32.
The Healthcare sector firm’s twelve-monthly sales growth has been 20.19% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was 20.19%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 99.39%. This publicly-traded company’s shares outstanding now amounts to $53.70 million, simultaneously with a float of $46.01 million. The organization now has a market capitalization sitting at $3.43 billion. At the time of writing, stock’s 50-day Moving Average stood at $63.20, while the 200-day Moving Average is $67.12.
Soleno Therapeutics Inc (SLNO) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Soleno Therapeutics Inc’s current insider ownership accounts for 13.42%, in contrast to 98.75% institutional ownership. Preceding that transaction, on Jul 01 ’25, Company’s insider sold 3,830 for 82.76, making the whole transaction’s value amount to 316,971. This particular insider is now the holder of 13,206 in total.
Soleno Therapeutics Inc (SLNO) Earnings and Revenue Records
Soleno Therapeutics Inc (NASDAQ: SLNO) Trading Performance Indicators
Let’s observe the current performance indicators for Soleno Therapeutics Inc (SLNO). It’s Quick Ratio in the last reported quarter now stands at 15.88. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 34.76.
In the same vein, SLNO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.85, a figure that is expected to reach 0.49 in the next quarter, and analysts are predicting that it will be 3.44 at the market close of one year from today.
Technical Analysis of Soleno Therapeutics Inc (SLNO)
Going through the that latest performance of [Soleno Therapeutics Inc, SLNO]. Its last 5-days volume of 3.5 million indicated improvement to the volume of 1.34 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 12.67% While, its Average True Range was 18.62.
Raw Stochastic average of Soleno Therapeutics Inc (SLNO) in the period of the previous 100 days is set at 6.60%, which indicates a major fall in contrast to 10.59% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 3.51 that was lower than 3.61 volatility it exhibited in the past 100-days period.
